Physician profile
Omkar Dave
NPI 1992949770
$10,112.71
in general payments reported to CMS, 2019-2025
25 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $170 · 2021: $987 · 2022: $1,127 · 2023: $6,271 · 2024: $655 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,518 · Food and Beverage: $1,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,517.53 |
| Food and Beverage | $1,914.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $6,133.71 | 2021-2025 | Catalyst Total Csr |
| Stryker Corporation | $2,684.50 | 2019-2025 | Mako, Inspace, T2 Alpha |
| Smith+Nephew, INC. | $203.33 | 2019-2025 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Biosure |
| Fidia Pharma USA INC. | $167.07 | 2020-2024 | Triluron |
| Medinc of Texas | $133.47 | 2023-2025 | |
| Depuy Synthes Sales INC. | $120.56 | 2021-2025 | Truespan Orthocord, Healix Knotless Peek, Dynacord |
| Ethicon US, LLC | $79.14 | 2021-2025 | Dermabond Prineo, Vistaseal |
| Ermi LLC | $73.71 | 2020-2021 | |
| Horizon Therapeutics Plc | $72.77 | 2019-2022 | |
| Baudax Bio INC. | $57.22 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $49.41 | 2025 | |
| Fujifilm Sonosite, INC. | $47.36 | 2019 | |
| Biedermann Motech, INC. | $42.17 | 2021 | |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Medtronic, INC. | $29.95 | 2023 | Swiftset |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Orthopaedics, INC. | $25.45 | 2024 | Integrity Orthopaedics |
| Avanos Medical | $25.15 | 2025 | Trivisc Sodium Hyaluronate |
| Electronic Waveform Lab, INC. | $24.79 | 2021 | |
| Arthrosurface Incorporated | $20.42 | 2019 | |
| Anika Therapeutics, INC. | $20.01 | 2022 | |
| Davol INC. | $18.68 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.08 | 2024 | |
| Medtronic USA, INC. | $14.10 | 2020 | |
| Innovation Technologies INC | $12.19 | 2022 | |
| Bioventus LLC | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$75,820.52 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omkar Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.